➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
AstraZeneca
McKinsey
Boehringer Ingelheim
Johnson and Johnson
Express Scripts

Last Updated: June 12, 2021

DrugPatentWatch Database Preview

Litigation Details for ADAPT PHARMA OPERATIONS LIMITED v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2016)


Email this page to a colleague

« Back to Dashboard

ADAPT PHARMA OPERATIONS LIMITED v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2016)

Docket   Get Started Free Date Filed 2016-10-21
Court District Court, D. New Jersey Date Terminated 2020-06-30
Cause 35:271 Patent Infringement Assigned To Brian R. Martinotti
Jury Demand None Referred To Joseph A. Dickson
Parties OPIANT PHARMACEUTICALS, INC.
Patents 9,211,253; 9,468,747; 9,561,177; 9,629,965; 9,775,838
Attorneys CHARLES MICHAEL LIZZA
Firms Saul Ewing Arnstein & Lehr LLP
Link to Docket External link to docket
Small Molecule Drugs cited in ADAPT PHARMA OPERATIONS LIMITED v. TEVA PHARMACEUTICALS USA, INC.
The small molecule drug covered by the patents cited in this case is   Get Started Free .

Details for ADAPT PHARMA OPERATIONS LIMITED v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2016)

Date Filed Document No. Description Snippet Link To Document
2018-11-06 128 Construction and Prehearing Statement for U.S. Patent No. 9,775,838 by ADAPT PHARMA LIMITED, ADAPT PHARMA OPERATIONS…2016 30 June 2020 2:16-cv-07721 830 Patent None District Court, D. New Jersey External link to document
2019-02-06 171 Amended Invalidity Contentions for U.S. Patent Nos. 9,211,253; 9,68,747; 9,561,177;9,629,965; and 9,775,838…2016 30 June 2020 2:16-cv-07721 830 Patent None District Court, D. New Jersey External link to document
2019-04-24 200 of United States Patent Numbers 9,211,253 (“‘253 patent”) and 9,468,747 (“747 patent”), Claim 10 of the… ‘253 patent and ‘747 patent, and Claim 29 of United States Patent No. 9,629,965 (“‘965 patent”).’ The…the ‘253 patent, Claims 3 and 33 of the ‘747 patent, Claims 5 and 27 of United States Patent No. 9,561,177…actuation.” (‘253 patent at 50:65—67; ‘747 patent at 53:42—44). Elsewhere, the ‘253 patent specification …9,561,177 (“177 patent”), and Claims 1 and 22 of the ‘965 patent. They have since resolved their dispute External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Mallinckrodt
Moodys
Medtronic
Johnson and Johnson
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.